US Stock MarketDetailed Quotes

Eterna Therapeutics (ERNA)

Watchlist
  • 13.630
  • +4.070+42.57%
Close May 15 16:00 ET
  • 12.999
  • -0.631-4.63%
Post 19:59 ET
15.90MMarket Cap-2.63P/E (TTM)

Eterna Therapeutics (ERNA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
755.88%582K
-94.12%1K
854.90%487K
47K
Operating revenue
--0
--0
--0
--0
--0
--0
755.88%582K
-94.12%1K
854.90%487K
--47K
Cost of revenue
0
0
0
0
0
0
-59.32%96K
0
-150.00%-60K
95K
Gross profit
0
0
0
0
0
0
389.29%486K
102.04%1K
892.75%547K
-48K
Operating expense
29.89%3.55M
-47.46%9.32M
-22.39%2.09M
-54.52%1.99M
-48.78%2.5M
-52.71%2.73M
-13.51%17.74M
-52.80%2.7M
-19.39%4.38M
19.42%4.88M
Selling and administrative expenses
14.78%1.63M
-60.68%5.16M
-7.92%1.42M
-71.67%958K
-64.96%1.37M
-67.07%1.42M
-9.97%13.13M
-64.65%1.54M
-16.50%3.38M
50.42%3.9M
-General and administrative expense
14.78%1.63M
-60.68%5.16M
-7.92%1.42M
-71.67%958K
-64.96%1.37M
-67.07%1.42M
-9.97%13.13M
-64.65%1.54M
-16.50%3.38M
50.42%3.9M
Research and development costs
46.29%1.92M
-9.73%4.16M
-41.62%676K
3.40%1.04M
15.10%1.14M
-10.22%1.31M
-22.23%4.6M
-14.85%1.16M
-27.83%1M
-34.16%987K
Operating profit
-29.89%-3.55M
45.98%-9.32M
22.36%-2.09M
48.03%-1.99M
49.28%-2.5M
52.83%-2.73M
16.57%-17.25M
53.22%-2.7M
30.34%-3.84M
-20.59%-4.93M
Net non-operating interest income expense
780.00%44K
100.86%56K
100.62%20K
101.84%31K
0
100.64%5K
-1,266.18%-6.5M
-733.51%-3.23M
-1,392.04%-1.69M
-3,420.83%-797K
Non-operating interest income
----
-66.67%83K
--47K
--31K
----
----
80.43%249K
----
----
----
Non-operating interest expense
----
-99.60%27K
----
----
----
----
999.67%6.75M
562.17%3.48M
1,392.04%1.69M
--797K
Total other finance cost
-780.00%-44K
----
----
----
----
-100.64%-5K
----
----
----
--797K
Other net income (expense)
62.63%-2.04M
76.56%-4.87M
178.69%510K
103.45%728K
-414.36%-635K
-7,712.86%-5.47M
-3,891.54%-20.76M
4,675.00%183K
-111,000.00%-21.07M
146.01%202K
Gain on sale of security
----
-20,778.57%-5.85M
-5,274.34%-5.85M
----
-476.47%-512K
-7,520.00%-5.33M
-117.95%-28K
130.61%113K
-1,135.00%-207K
-25.68%136K
Special income (charges)
---2.04M
103.68%765K
--5.88M
103.52%734K
--0
----
-5,981.29%-20.8M
--0
---20.86M
119.30%66K
-Less:Restructuring and merger&acquisition
----
--0
--0
--0
--0
----
44.07%-66K
--0
--0
44.07%-66K
-Less:Impairment of capital assets
--2.04M
----
----
----
----
----
----
----
----
----
-Less:Other special charges
----
-103.67%-765K
---5.88M
-103.52%-734K
----
----
4,435.65%20.86M
--0
--20.86M
----
Other non- operating income (expenses)
----
207.14%215K
--479K
---6K
---123K
---135K
120.96%70K
----
----
----
Income before tax
32.32%-5.55M
68.26%-14.13M
72.79%-1.56M
95.36%-1.23M
43.25%-3.14M
-23.35%-8.19M
-105.39%-44.51M
6.64%-5.75M
-374.94%-26.59M
-22.69%-5.53M
Income tax
-600.00%-40K
-250.00%-45K
-663.64%-62K
-50.00%6K
0.00%3K
100.00%8K
1,100.00%30K
375.00%11K
250.00%12K
-25.00%3K
Net income
32.87%-5.51M
68.38%-14.08M
73.92%-1.5M
95.34%-1.24M
43.23%-3.14M
-23.39%-8.2M
-105.55%-44.54M
6.40%-5.76M
-375.84%-26.6M
-22.65%-5.53M
Net income continuous Operations
32.87%-5.51M
68.38%-14.08M
73.92%-1.5M
95.34%-1.24M
43.23%-3.14M
-23.39%-8.2M
-105.55%-44.54M
6.40%-5.76M
-375.84%-26.6M
-22.65%-5.53M
Minority interest income
Net income attributable to the parent company
32.87%-5.51M
68.38%-14.08M
73.92%-1.5M
95.34%-1.24M
43.23%-3.14M
-23.39%-8.2M
-105.55%-44.54M
6.40%-5.76M
-375.84%-26.6M
-22.65%-5.53M
Preferred stock dividends
0.00%16K
0.00%8K
0.00%8K
0.00%16K
0.00%8K
0.00%8K
Other preferred stock dividends
Net income attributable to common stockholders
32.87%-5.51M
68.35%-14.1M
73.82%-1.51M
95.34%-1.24M
43.16%-3.15M
-23.39%-8.2M
-105.47%-44.56M
6.40%-5.77M
-375.84%-26.6M
-22.61%-5.54M
Basic earnings per share
-208.89%-173.75
95.42%-56
99.41%-0.25
99.80%-3.75
96.02%-15.25
87.80%-56.25
20.00%-1.22K
90.16%-42.086
-377.02%-1.84K
-20.31%-383.5
Diluted earnings per share
-208.89%-173.75
95.42%-56
99.41%-0.25
99.80%-3.75
96.02%-15.25
87.80%-56.25
20.00%-1.22K
90.16%-42.086
-377.02%-1.84K
-20.31%-383.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 000000755.88%582K-94.12%1K854.90%487K47K
Operating revenue --0--0--0--0--0--0755.88%582K-94.12%1K854.90%487K--47K
Cost of revenue 000000-59.32%96K0-150.00%-60K95K
Gross profit 000000389.29%486K102.04%1K892.75%547K-48K
Operating expense 29.89%3.55M-47.46%9.32M-22.39%2.09M-54.52%1.99M-48.78%2.5M-52.71%2.73M-13.51%17.74M-52.80%2.7M-19.39%4.38M19.42%4.88M
Selling and administrative expenses 14.78%1.63M-60.68%5.16M-7.92%1.42M-71.67%958K-64.96%1.37M-67.07%1.42M-9.97%13.13M-64.65%1.54M-16.50%3.38M50.42%3.9M
-General and administrative expense 14.78%1.63M-60.68%5.16M-7.92%1.42M-71.67%958K-64.96%1.37M-67.07%1.42M-9.97%13.13M-64.65%1.54M-16.50%3.38M50.42%3.9M
Research and development costs 46.29%1.92M-9.73%4.16M-41.62%676K3.40%1.04M15.10%1.14M-10.22%1.31M-22.23%4.6M-14.85%1.16M-27.83%1M-34.16%987K
Operating profit -29.89%-3.55M45.98%-9.32M22.36%-2.09M48.03%-1.99M49.28%-2.5M52.83%-2.73M16.57%-17.25M53.22%-2.7M30.34%-3.84M-20.59%-4.93M
Net non-operating interest income expense 780.00%44K100.86%56K100.62%20K101.84%31K0100.64%5K-1,266.18%-6.5M-733.51%-3.23M-1,392.04%-1.69M-3,420.83%-797K
Non-operating interest income -----66.67%83K--47K--31K--------80.43%249K------------
Non-operating interest expense -----99.60%27K----------------999.67%6.75M562.17%3.48M1,392.04%1.69M--797K
Total other finance cost -780.00%-44K-----------------100.64%-5K--------------797K
Other net income (expense) 62.63%-2.04M76.56%-4.87M178.69%510K103.45%728K-414.36%-635K-7,712.86%-5.47M-3,891.54%-20.76M4,675.00%183K-111,000.00%-21.07M146.01%202K
Gain on sale of security -----20,778.57%-5.85M-5,274.34%-5.85M-----476.47%-512K-7,520.00%-5.33M-117.95%-28K130.61%113K-1,135.00%-207K-25.68%136K
Special income (charges) ---2.04M103.68%765K--5.88M103.52%734K--0-----5,981.29%-20.8M--0---20.86M119.30%66K
-Less:Restructuring and merger&acquisition ------0--0--0--0----44.07%-66K--0--044.07%-66K
-Less:Impairment of capital assets --2.04M------------------------------------
-Less:Other special charges -----103.67%-765K---5.88M-103.52%-734K--------4,435.65%20.86M--0--20.86M----
Other non- operating income (expenses) ----207.14%215K--479K---6K---123K---135K120.96%70K------------
Income before tax 32.32%-5.55M68.26%-14.13M72.79%-1.56M95.36%-1.23M43.25%-3.14M-23.35%-8.19M-105.39%-44.51M6.64%-5.75M-374.94%-26.59M-22.69%-5.53M
Income tax -600.00%-40K-250.00%-45K-663.64%-62K-50.00%6K0.00%3K100.00%8K1,100.00%30K375.00%11K250.00%12K-25.00%3K
Net income 32.87%-5.51M68.38%-14.08M73.92%-1.5M95.34%-1.24M43.23%-3.14M-23.39%-8.2M-105.55%-44.54M6.40%-5.76M-375.84%-26.6M-22.65%-5.53M
Net income continuous Operations 32.87%-5.51M68.38%-14.08M73.92%-1.5M95.34%-1.24M43.23%-3.14M-23.39%-8.2M-105.55%-44.54M6.40%-5.76M-375.84%-26.6M-22.65%-5.53M
Minority interest income
Net income attributable to the parent company 32.87%-5.51M68.38%-14.08M73.92%-1.5M95.34%-1.24M43.23%-3.14M-23.39%-8.2M-105.55%-44.54M6.40%-5.76M-375.84%-26.6M-22.65%-5.53M
Preferred stock dividends 0.00%16K0.00%8K0.00%8K0.00%16K0.00%8K0.00%8K
Other preferred stock dividends
Net income attributable to common stockholders 32.87%-5.51M68.35%-14.1M73.82%-1.51M95.34%-1.24M43.16%-3.15M-23.39%-8.2M-105.47%-44.56M6.40%-5.77M-375.84%-26.6M-22.61%-5.54M
Basic earnings per share -208.89%-173.7595.42%-5699.41%-0.2599.80%-3.7596.02%-15.2587.80%-56.2520.00%-1.22K90.16%-42.086-377.02%-1.84K-20.31%-383.5
Diluted earnings per share -208.89%-173.7595.42%-5699.41%-0.2599.80%-3.7596.02%-15.2587.80%-56.2520.00%-1.22K90.16%-42.086-377.02%-1.84K-20.31%-383.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More